Kestra Advisory Services LLC Increases Position in Aurora Cannabis Inc. (NYSE:ACB)

Kestra Advisory Services LLC increased its stake in Aurora Cannabis Inc. (NYSE:ACBGet Rating) by 85.9% in the first quarter, HoldingsChannel.com reports. The firm owned 19,567 shares of the company’s stock after acquiring an additional 9,041 shares during the quarter. Kestra Advisory Services LLC’s holdings in Aurora Cannabis were worth $78,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Ausdal Financial Partners Inc. purchased a new position in Aurora Cannabis during the 4th quarter valued at about $3,465,000. Merlin Capital LLC purchased a new position in Aurora Cannabis during the 4th quarter valued at about $2,110,000. Dimensional Fund Advisors LP increased its holdings in Aurora Cannabis by 78.0% during the 4th quarter. Dimensional Fund Advisors LP now owns 667,099 shares of the company’s stock valued at $3,609,000 after acquiring an additional 292,222 shares in the last quarter. Mirabella Financial Services LLP purchased a new position in Aurora Cannabis during the 4th quarter valued at about $1,461,000. Finally, ETF Managers Group LLC increased its holdings in Aurora Cannabis by 1.5% during the 4th quarter. ETF Managers Group LLC now owns 11,435,872 shares of the company’s stock valued at $62,897,000 after acquiring an additional 169,935 shares in the last quarter. Hedge funds and other institutional investors own 15.47% of the company’s stock.

Aurora Cannabis Price Performance

ACB opened at $1.36 on Thursday. The company’s 50 day simple moving average is $1.63 and its 200 day simple moving average is $3.04. The company has a debt-to-equity ratio of 0.32, a quick ratio of 4.76 and a current ratio of 5.85. Aurora Cannabis Inc. has a 1 year low of $1.21 and a 1 year high of $8.69. The stock has a market capitalization of $308.44 million, a PE ratio of -0.29 and a beta of 2.81.

Aurora Cannabis (NYSE:ACBGet Rating) last released its earnings results on Thursday, May 12th. The company reported ($1.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.16) by ($0.88). Aurora Cannabis had a negative return on equity of 25.80% and a negative net margin of 542.50%. The company had revenue of $39.82 million during the quarter, compared to analyst estimates of $40.58 million. As a group, sell-side analysts expect that Aurora Cannabis Inc. will post -1.65 EPS for the current year.

Analyst Ratings Changes

Several equities analysts have weighed in on the stock. Stifel Nicolaus upgraded shares of Aurora Cannabis from a “sell” rating to a “hold” rating and set a $2.15 target price for the company in a report on Monday, June 6th. Cantor Fitzgerald upgraded shares of Aurora Cannabis from a “neutral” rating to an “overweight” rating in a report on Friday, June 24th. Finally, CIBC lowered their price target on shares of Aurora Cannabis from C$6.50 to C$3.75 in a report on Monday, May 16th. Two research analysts have rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat.com, Aurora Cannabis has a consensus rating of “Hold” and a consensus price target of $5.23.

About Aurora Cannabis

(Get Rating)

Aurora Cannabis Inc produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients.

Read More

Want to see what other hedge funds are holding ACB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aurora Cannabis Inc. (NYSE:ACBGet Rating).

Institutional Ownership by Quarter for Aurora Cannabis (NYSE:ACB)

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.